Pessac, France

Jérôme Besse


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 24(Granted Patents)


Company Filing History:


Years Active: 2006

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Jérôme Besse

Introduction

Jérôme Besse is a notable inventor based in Pessac, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of mucositis related to cancer therapies. His innovative approach has led to the development of a unique pharmaceutical composition that addresses a critical need in patient care.

Latest Patents

Jérôme Besse holds a patent for a pharmaceutical composition intended for the prevention and treatment of radiomucositis and chemomucositis. This invention focuses on a composition designed to adhere to mucous membranes, effectively preventing or treating mucositis induced by radiotherapy or chemotherapy. The formulation includes an effective amount of an antiradical compound mixed with a vehicle that is liquid at room temperature and gels at mucous membrane temperature, ensuring adherence and efficacy.

Career Highlights

Jérôme Besse is associated with Laboratoire L. Lafon, where he has been instrumental in advancing pharmaceutical innovations. His work has not only contributed to the scientific community but has also had a direct impact on improving the quality of life for patients undergoing cancer treatments.

Collaborations

Throughout his career, Jérôme has collaborated with talented individuals such as Tam Nguyen and Joëlle Leyder. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.

Conclusion

Jérôme Besse's contributions to the field of pharmaceuticals exemplify the importance of innovation in addressing healthcare challenges. His patented work in mucositis treatment showcases his commitment to improving patient outcomes through scientific advancement.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…